Relationship of HbA1c with body weight change over 4 years from starting insulin therapy in people with type 2 diabetes: the CREDIT study

被引：0
|
作者：
Balkau, B. [1 ]
Freemantle, N. [2 ]
Calvi-Gries, F. [3 ]
Pilorget, V. [4 ]
Vincent, M. [4 ]
Home, P. [5 ]
机构：
[1] Univ Paris 11, INSERM, U1018, UMRS 1018, Villejuif, France
[2] UCL, London WC1E 6BT, England
[3] AtlanStat, Reze, France
[4] Sanofi, Paris, France
[5] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
110
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [21] What are the HbA1c thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care?
    Hinton, W.
    McGovern, A. P.
    Whyte, M.
    Curtis, B. H.
    McCullough, K.
    van Brunt, K.
    Calderara, S.
    de Lusignan, S.
    DIABETOLOGIA, 2016, 59 : S416 - S417
  • [22] Survival in people with type 2 diabetes as a function of HbA1c
    Balkau, Beverley
    Simon, Dominique
    LANCET, 2010, 375 (9713): : 438 - 440
  • [23] Seasonal changes in body composition and blood HbA1c levels without weight change in male patients with type 2 diabetes treated with insulin
    Sohmiya, M
    Kanazawa, I
    Kato, Y
    DIABETES CARE, 2004, 27 (05) : 1238 - 1239
  • [24] HbA1c at initiation of insulin therapy in Type 2 diabetes: lessons not being learned
    Whitty, H. J.
    Mckay, M.
    Adamson, K. A.
    Walker, J. D.
    DIABETIC MEDICINE, 2008, 25
  • [25] HbA1c reduction with tirzepatide in people with type 2 diabetes: a mediation analysis using body weight loss as a factor
    Vilsboll, T.
    Nicolay, C.
    Malecki, M.
    Thieu, V. Thuyanh
    Chivukula, K.
    Kiljanski, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S324 - S325
  • [26] Comparing insulin glargine (GLAR) with insulin detemir (DET) - effects on HbA1c on weight change and insulin dose in patients with type 2 diabetes
    Dailey, G.
    Admane, K.
    Mercier, F.
    Owens, D.
    DIABETOLOGIA, 2009, 52 : S381 - S381
  • [27] Longitudinal change of HbA1c depending on initial antidiabetic therapy in Type 2 diabetes
    Kwon, Mi-Kwang
    Rhee, Sang Youl
    Chon, Suk
    Jeong, In-Kyung
    Oh, Seungioon
    Ahn, Kuy Jeung
    Chung, Ho Yeon
    Woo, Jeong-taek
    Kim, Sung-Woon
    Kim, Jim-Woo
    Kim, Young Seol
    Choi, Young Kil
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S72 - S73
  • [28] Automated Insulin Delivery for People With Type 1 Diabetes and High HbA1c: Is It Time?
    Wheeler, Benjamin J.
    Boucsein, Alisa
    DIABETES CARE, 2025, 48 (01) : 50 - 51
  • [29] Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up
    Wilding, J.
    Bailey, C.
    Rigney, U.
    Blak, B.
    Kok, M.
    Emmas, C.
    PRIMARY CARE DIABETES, 2017, 11 (05) : 437 - 444
  • [30] THE RELATIONSHIP BETWEEN POOR ADHERENCE AND HBA1C AND WEIGHT CHANGES IN PATIENTS WITH TYPE 2 DIABETES
    Ramos, M.
    Foos, V
    Ferrufino, C.
    Yu-Isenberg, K.
    Lamotte, M.
    VALUE IN HEALTH, 2018, 21 : S138 - S138
12345